The inability to distinguish failures of treatment of
A practical method to distinguish failures of antimalarial phism of these genes have been used to genotype P. falciparum isolates [4, 6 -8] . However, the degree of genetic heterogeneity treatment (recrudescences) from reinfections would represent an important advance. The inability to separate new infections that exists within these genes is not discernible with allelespecific hybridization or size polymorphism studies alone from those for which treatment fails limits the ability to interpret results of antimalarial treatment trials conducted in areas [1 -5, 9] . Single-strand conformational polymorphism (SSCP) analyof malaria transmission. The traditional approach has been to prevent reinfection by hospitalizing patients in a malaria-free sis is a simple and sensitive technique based on the differential mobility of single-stranded DNA in nondenaturing gels [10] . area for at least 21 days. In many regions and situations, this approach is neither practical nor possible.
This technique has the potential to discriminate single base pair differences between DNA fragments and has been used Genetic fingerprinting or genotyping of Plasmodium falciparum strains may be a solution to the problem of separating true to genotype a variety of microorganisms [11 -13] . We recently employed this technique on a single gene (MSP-2) to differentirecrudescences from new infections and would facilitate the testing of antimalarial drugs in areas of endemicity. The genes ate 10 paired primary and recrudescent isolates from unrelated P. falciparum infections [2] . The objectives of this study were encoding the merozoite surface proteins, MSP-1 [1 -4] and MSP-2 [2 -5] , display extreme size and allelic polymorphism.
to confirm that PCR SSCP analysis of one or more polymorphic genes could reliably distinguish infections for which treatment PCR-based assays to demonstrate size and sequence polymorfailed from unrelated infections with a sample size adequate to precisely estimate the sensitivity and specificity of this technique and to define the field applicability of an SSCP genotyp-of Thailand without malaria transmission, thereby excluding examination. The SSCP pattern of each recrudescent isolate was compared with that of its matched primary isolate and with reinfection.
Whole blood samples were collected from all study subjects those of all other primary isolates. Since primary infections are often due to two or more clones of P. falciparum [2-4, 7, 9, on hospital days 0, 2, 3, and 7 and at the time of treatment failure. Whole blood was collected in EDTA and acid citrate 16 -18], the primary SSCP pattern may have one or more bands than does the recrudescent SSCP pattern. Therefore, our dextrose and frozen at 020ЊC. Each tube was labeled with the study subjects' name, hospital number, and date. criterion for identity that was that the mobility of each band within the recrudescent SSCP pattern had to match a band within the primary SSCP pattern [2] .
DNA Purification, PCR Amplification, and Analysis
Because mobility differs slightly between gels, the BioImage System with Whole Band Analysis was used to standardize Genomic DNA was extracted from paired primary and recrudescent whole blood samples (200 mL) with use of Qiagen across gels. The stringency for identity was set at 2.5%. This stringency setting was determined after assessing interassay columns (Qiagen, Chatsworth, CA) as per the manufacturer's directions. Oligonucleotide primers were synthesized as prevariability by repeating amplification and SSCP analysis of the same 10 samples three times. At this setting, the SSCP patterns viously described [2, 8] . Amplification was performed in 11 PCR buffer (Promega, Madison, WI) with 1.5 mM MgCl 2 , of the reference, primary, and recrudescent isolates were found to be reproducible (authors' unpublished data). The BioImage 200 mM of each dNTP, 25 pmol of each primer, and 1.25 U of Taq polymerase (Promega) in a total volume of 50 mL. The System with Whole Band Analysis aligns the isolates in order of similarity automatically. amplification program consisted of a cycle of preheating to 95ЊC for 5 minutes followed by 35 cycles at 94ЊC for 1 minute; annealing at 50ЊC (MSP-1), 45ЊC (MSP-2), or 55ЊC (GLURP) Data Analysis for 1 minute; and extension at 72ЊC for 2 minutes. PCR prodSensitivity was defined as the number of fingerprint matches ucts underwent electrophoresis on a 2% agarose gel and were divided by the number of treatment failures. Specificity was gel-purified with use of Qiagen columns. PCR products of defined as the number of fingerprint nonmatches divided by MSP-2 were also digested to completion with RsaI (GIBCO the number of unrelated infections. As a surrogate estimate of BRL, Gaithersburg, MD). Products were extracted with chlorospecificity, each recrudescent isolate was compared with the form, precipitated with ethanol, resuspended in water, and anaother 35 unrelated primary isolates (1,260 combinations) [4] . lyzed by electrophoresis on a 4% NuSieve agarose gel (FMC The probability of treatment failure given a matching fingerBioproducts, Rockland, ME) and by SSCP genotyping.
print is analogous to a positive predictive value and was derived from Bayes' theorem of conditional probabilities as follows: (sensitivity 1 prevalence of recrudescent infections)/([sensitiv-PCR SSCP Analysis ity 1 prevalence of recrudescent infections] / [(1 0 specific-PCR products were denatured before analysis by adding ity) 1 prevalence of reinfections]) [19, 20] . The probability of 1 mL of 0.5 M NaOH/10 mM EDTA to 100 -200 ng of amplireinfection given a nonmatching fingerprint is analogous to a fied DNA in 9 mL of water followed by heating at 42ЊC for 5 negative predictive value and was calculated as follows: (speciminutes. Following the addition of load buffer (0.1% xylene ficity 1 prevalence of reinfections)/([specificity 1 prevalence cyanol, 0.1% bromophenol blue in formamide), samples were of reinfections] / [(1 0 sensitivity) 1 prevalence of recrudesimmediately placed on ice and then loaded onto a nondenaturcent infections]). In the setting of recurrent parasitemia, the ing 10% polyacrylamide minigel (1 mm; Novex, San Diego); prevalence of reinfections was calculated as follows: 1 0 prevthe gels were run under constant voltage with 5% glycerol alence of treatment failures. in 0.81 glycerol tolerant buffer (United States Biochemicals,
The exact conditional distribution (based on binomial distriCleveland) for 2,100 volt hours for MSP-2, 720 volt hours for bution) was used to calculate 95% confidence intervals (Statrestriction fragment length polymorphism (RFLP) of MSP-2, Xact-3, version 3.0.2; Cytel Software Corporation, Cambridge, 1,056 volt hours for MSP-1, or 2,600 volt hours for GLURP.
MA). The multiplication rule of probability theory [21] was Lanes containing a 1-kilobase ladder, a 123-bp ladder (GIBCO utilized to determine the probability that any two unrelated BRL), and reference strains that had been similarly treated primary isolates would have the same polymorphism at one or were used to standardize SSCP patterns. The gels were stained more loci. It was assumed that all loci were unlinked (statistiwith silver (Silverstain Plus Kit; Bio-Rad, Richmond, CA) and cally independent) and that the genotypes of our study isolates dried. Comparisons of primary and recrudescent isolates were were representative of the parasite population at large. performed by running samples side-by-side in the same gel electrophoresis run.
Results SSCP patterns of DNA fragments were scanned, digitized, and analyzed by using the BioImage System with Whole Band Sixty patients for whom therapy failed during follow-up in Bangkok (an area without malaria transmission) were identiAnalysis, version 3 (Millipore, Ann Arbor, MI), and by visual / 9c64$$ap24 Assuming that the loci are unlinked, the probability of any two unrelated primary isolates having the same polymorphism at both MSP-1 and MSP-2 genes is three in 100,000, and at MSP-1, MSP-2, and GLURP genes, it is five in 10,000,000. Results of SSCP analysis of MSP-1 genes of all 72 isolates lated strains with similar alleles (demes) or related clones is unknown.
The utility of this methodology can be assessed by treating fied; isolates from each patient exhibited an RI type (treatment failure between day 7 and day 28) of drug resistance [22] . The it as if it were a diagnostic test. The number of fingerprint matches divided by the number of treatment failures is analofirst 37 paired primary and recrudescent isolates identified were chosen for analysis. One isolate could not be amplified. The gous to sensitivity (100% in this study), while the number of fingerprint nonmatches divided by the number of unrelated remaining 36 paired isolates were analyzed by PCR SSCP analysis of a portion of the MSP-1 gene, the MSP-2 gene, infections is analogous to specificity (according to the MSP-1 gene, estimated to be 99.7% in this study). The utility of PCR an RFLP of the MSP-2 gene, and the GLURP gene (figures 1 and 2). SSCP analysis is affected by the reinfection rate (prevalence), the ability of the test to identify treatment failures with a matchIn every case (36 [100%] of 36 [95% CI, 90% -100%]), the PCR SSCP pattern of the recrudescent isolates matched or was ing fingerprint (sensitivity), and the variability in the genes extracted from P. falciparum isolates recovered from the study contained within the pattern of the primary isolate. In one case, the pattern of the primary isolate was initially missing some population (specificity). The probability of treatment failure given a matching fingerprint and reinfection given a nonmatchbands present in the pattern of its corresponding recrudescent isolate. The absent bands were visualized after loading ining fingerprint is equivalent to the positive predictive value and the negative predictive value, respectively. Both the positive creased amounts of the PCR product from the primary isolate, thus indicating that these bands likely corresponded to a parapredictive value and the negative predictive value are affected by the reinfection rate; however, the positive predictive value site clone present in low numbers in the initial infection.
The genetic markers used represent highly polymorphic loci. is also affected by the specificity, and the negative predictive value is affected by the sensitivity. For the 36 primary isolates, 34 unique SSCP patterns of the MSP-1 block 2 locus, 32 unique SSCP patterns of the MSP-2
Even assuming a worst case scenario for specificity (i.e., reinfection rates of up to 50% and variability within P. falcipagene, and 24 SSCP patterns of the GLURP gene were observed. Each recrudescent isolate was compared with the other 35 unrerum genes as low as 90%), a matching fingerprint has a chance of ú90% of indicating a treatment failure. This probability lated primary isolates (1,260 combinations) to determine if SSCP analysis could discriminate unrelated infections. In this improves with lower reinfection rates and higher specificity and is nearly 100% with our observed specificity at all rates. study, unrelated primary infections were used as surrogates for true reinfections. By using all three genes, two isolate pairs At reinfection rates of ú20%, sensitivity must exceed 97.5%
/ 9c64$$ap24 03-15-99 10:44:43 cida UC: CID SSCP gels (as in figure 1) were scanned, digitized, and compared by using the BioImage System with Whole Band Analysis (version 3; Millipore, Ann Arbor, MI). P Å patient; 1 Å primary isolate; 2 Å recrudescent isolate. Percent relatedness is provided by the scale at the bottom of the figure. to exceed 90% probability that a nonmatching fingerprint is a identical to, or a subpopulation of, its primary isolate. Recrudescent isolates were distinct from all but two of the unrelated reinfection, while 99.9% specificity will yield ú95% probability at reinfection rates as low as 2% (data available from primary isolates. authors).
The inability to differentiate new P. falciparum infections from recrudescence limits the ability to determine true drug efficacy when treatment studies are performed in areas where Discussion malaria is endemic. This concept is illustrated in a recent trial from Africa in which pyronaridine treatment was reported to be The availability of a practical method to distinguish P. falcip-100% efficacious [23] . Because of the inability to differentiate arum reinfections from recrudescent infections would facilitate infections for which treatment fails from reinfections, patients antimalarial drug studies in areas with active malaria transmiswere only followed up for 14 days. In contrast, the rates of sion. In this study, we confirmed that PCR SSCP analysis of efficacy for pyronaridine regimens assessed in a malaria-free polymorphic loci, such as the MSP-1 or MSP-2 gene, is such area of Thailand were only 63% and 88%, and 21 of the 22 a method. PCR SSCP analysis of paired primary and recrudescent isolates established that each recrudescent isolate was recrudescences occurred after day 14 [24, 25] . Therefore, the / 9c64$$ap24 03-15-99 10:44:43 cida UC: CID actual 28-day RI treatment failure rate in Africa is unknown, failed will be ú90%. The probability that a nonmatching fingerprint represents a reinfection depends on the specificity and and the reported efficacy rate of 100% may be misleading. In studies designed to determine the efficacy of new antimalarial the reinfection rate. Because the specificity of PCR SSCP analysis of either the MSP-1 or MSP-2 gene was ú99% we believe compounds, adequate follow-up time to detect RI treatment failures is necessary. In assessing antimalarial drugs already in that analysis of only one of these genes will be sufficient in most cases. Because participants in this study were from a use, accurately identifying RI treatment failures is important since these are often the first indicators of emerging drug resislarge area of western Thailand and eastern Myanmar, we were concerned that the variability observed might not be representatance.
The traditional strategy to separate infections for which treattive of that seen for more isolated populations for whom this technique will be used. However, several studies have found ment fails from reinfections is to hospitalize patients for 21 days and then follow up subjects as outpatients for an additional marked genetic variability P. falciparum isolates, even in isolated regions (reviewed in [28] ). Furthermore, in an ongoing week. Clearly, this approach has many limitations. It is expensive, subjects often drop out when they feel well, malaria transanalysis of infections in isolated populations, we have observed that almost all isolates are unique by the genetic markers demission occurs in hospitals in some areas, and 28 days may not be adequate follow-up for treatment with drugs with a long scribed (authors' unpublished data). In this study, we observed a high sensitivity; therefore, a rate in the villages where a drug trial was performed, and the incidence of new infections was subtracted from the overall nonmatching fingerprint had a high probability of representing a reinfection, even at very low reinfection rates. However, if treatment failure rate to estimate the actual treatment failure rate. This method is a potential solution, but it is limited by sensitivity is lower than our estimates, the probability that a nonmatching fingerprint represents a reinfection falls. Our the cost and effort necessary to radically cure and follow up a cohort of subjects concurrently. In many situations, it is not study subjects were largely nonimmune. A study of semiimmune individuals should be performed in a malaria-free area possible to follow a cohort that is similar to the patients receiving treatment; in addition, study subjects may be at higher risk to determine if the high sensitivity that we observed is also present for such populations. This study also used a surrogate of reacquiring malaria than estimated by the cohort study.
Baird and colleagues [27] added a halofantrine treatment for reinfections, and the results ideally should be confirmed for naturally reinfected patients. arm to estimate the reinfection rate. This strategy is also a potential solution, but it is limited by the number of subjects Genotyping methods, such as those we describe, also have potential limitations. An individual infected with a given necessary to precisely estimate the reinfection rate and it assumes that halofantrine is 100% efficacious and that halofan-P. falciparum genotype may be reinfected with the same genotype. If it does occur, genotyping methods may overestimate trine does not continue to suppress new infections after treatment. SSCP fingerprinting could be used in conjunction with the treatment failure rate. Additional possible limitations are as follows. PCR-based methods may be limited by the inability either of the epidemiological methods described above to determine the true treatment failure rate.
to detect mixed infections in which one parasite population greatly exceeds other populations in the analyzed sample beWe previously reported the first use of SSCP analysis of a single gene to differentiate 10 infections for which treatment cause of differences in parasite inhibition, synchronization, or sequestration. Different clones of a primary P. falciparum isofailed from reinfections [2] . The present study was designed to confirm and extend our previous results by analyzing a late may be released from the liver at intervals or may differentially sequester and therefore not be detected in the sample number of polymorphic markers amplified from more isolates. A large sample of paired primary and recrudescent isolates collected on day 0. Because of this concern, we collected blood samples on days 2, 3, and 7. collected in a malaria-free area was needed to determine the sensitivity (with small confidence intervals) of this technique.
Despite these theoretical considerations, it is of note that all recrudescent isolates were always apparent in the correspondWe defined sensitivity as the number of recrudescent isolates that matched or were contained within the fingerprints of the ing primary infection. Last, our analysis was not blinded. To optimize accuracy, we thought that paired isolates should be primary isolates (36 [100%] of 36 [95% CI, 90% -100%]). Since true reinfections are difficult to identify, a surrogate for run side-by-side. SSCP gels were digitized, and matching of band patterns was performed by a software system, thereby specificity was defined as the number of recrudescent isolates that were unique from all unrelated primary isolates (1, 258 decreasing the potential for bias. In summary, by using PCR SSCP analysis of paired primary [99.8%] of 1,260 [95% CI, 99.4% -100%]).
The present study indicates that even in areas with high and recrudescent isolates, we have demonstrated that recrudescent isolates are identical to, or a subpopulation of, the primary reinfection rates, when a pair of isolates with matching SSCP fingerprints is recovered from an individual, the probability isolates and are distinct from unrelated isolates. 
